NO20015330L - Ny promoter for genekspresjon - Google Patents
Ny promoter for genekspresjonInfo
- Publication number
- NO20015330L NO20015330L NO20015330A NO20015330A NO20015330L NO 20015330 L NO20015330 L NO 20015330L NO 20015330 A NO20015330 A NO 20015330A NO 20015330 A NO20015330 A NO 20015330A NO 20015330 L NO20015330 L NO 20015330L
- Authority
- NO
- Norway
- Prior art keywords
- promoter
- antibiotic
- sequence
- gene expression
- promoter sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Oppfinnelsen tilveiebringer et isolert DNA-molekyl som innbefatter en promotersekvens, der nevnte promotersekvens er en Pm- eller en Pu-promoter i et TOL-plasmid, der nevnte promotersekvens har sekvensmodifiseringer i dens 10 region sammen med DNA-konstruksjoner, ekspresjonsvektorer og transformerte celler inneholdende slike molekyler. Også tilveiebragt i oppfinnelsen er en fremgangsmåte for å undersøke promoteraktivitet, som innbefatter å uttrykke et antibiotikumresistensgen under kontroll av promoteren som skal bli undersøkt i en antibiotikummottakelig (dvs. sensitiv) vertscelle og vurdere veksten av nevnte celle i nærvær av nevnte antibiotikum.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9910413.5A GB9910413D0 (en) | 1999-05-05 | 1999-05-05 | Novel promoter of gene expression |
PCT/GB2000/001729 WO2000068375A2 (en) | 1999-05-05 | 2000-05-05 | Modified pm and pu promoters of tol plasmids |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20015330L true NO20015330L (no) | 2001-01-02 |
NO20015330D0 NO20015330D0 (no) | 2001-10-31 |
Family
ID=10852871
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20015330A NO20015330D0 (no) | 1999-05-05 | 2001-10-31 | Ny promoter for genekspresjon |
Country Status (5)
Country | Link |
---|---|
US (1) | US20030003525A1 (no) |
EP (1) | EP1177284A2 (no) |
GB (1) | GB9910413D0 (no) |
NO (1) | NO20015330D0 (no) |
WO (1) | WO2000068375A2 (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1925672A1 (en) | 2001-06-22 | 2008-05-28 | Syngeta Participations AG | Abiotic stress responsive polynucleotides and polypeptides |
GB0615556D0 (en) | 2006-08-04 | 2006-09-13 | Leiv Eiriksson Nyfotek As | Enhanced Expression Method |
GB0625651D0 (en) | 2006-12-21 | 2007-01-31 | Leiv Eiriksson Nyskaping As | Enhanced expression from the pm promoter |
US20100099198A1 (en) * | 2008-07-11 | 2010-04-22 | Board Of Regents, The University Of Texas System | Apparatus and system for pattern recognition sensing for biomolecules |
CA2950304A1 (en) | 2014-06-18 | 2015-12-23 | Calysta, Inc. | Nucleic acids and vectors for use with methanotrophic bacteria |
GB201709308D0 (en) * | 2017-06-12 | 2017-07-26 | Univ Manchester | Variant nucleotide library |
-
1999
- 1999-05-05 GB GBGB9910413.5A patent/GB9910413D0/en not_active Ceased
-
2000
- 2000-05-05 WO PCT/GB2000/001729 patent/WO2000068375A2/en active Search and Examination
- 2000-05-05 EP EP00927518A patent/EP1177284A2/en not_active Withdrawn
-
2001
- 2001-10-31 NO NO20015330A patent/NO20015330D0/no not_active Application Discontinuation
- 2001-11-05 US US10/012,898 patent/US20030003525A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030003525A1 (en) | 2003-01-02 |
WO2000068375A3 (en) | 2001-03-15 |
GB9910413D0 (en) | 1999-07-07 |
WO2000068375A2 (en) | 2000-11-16 |
EP1177284A2 (en) | 2002-02-06 |
NO20015330D0 (no) | 2001-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rogers et al. | Functional repair of a mutant chloride channel using a trans-splicing ribozyme | |
Zhao et al. | S‐sulfhydration of MEK 1 leads to PARP‐1 activation and DNA damage repair | |
Zhou et al. | Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology | |
May et al. | Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation | |
Chen et al. | Maintenance of amelogenin gene expression by transformed epithelial cells of mouse enamel organ | |
Nasim et al. | HnRNP G and Tra2β: opposite effects on splicing matched by antagonism in RNA binding | |
Chuvpilo et al. | Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes | |
Phielix et al. | Mitochondrial function and insulin resistance during aging–a mini-review | |
US20070259343A1 (en) | Somatic transfer of modified genes to predict drug effects | |
Zimmer et al. | Mouse heart Na+ channels: primary structure and function of two isoforms and alternatively spliced variants | |
Hentschel et al. | Destabilized eYFP variants for dynamic gene expression studies in C orynebacterium glutamicum | |
Takeyama et al. | Fo portion of Escherichia coli H+-ATPase. Carboxyl-terminal region of the b subunit is essential for assembly of functional Fo. | |
Yuan et al. | Investigations of the Navβ1b sodium channel subunit in human ventricle; functional characterization of the H162P Brugada syndrome mutant | |
CN101400697A (zh) | 寻常鱼鳞病、特异反应性和其他病症的预防/治疗 | |
CN107173817A (zh) | sir2蛋白在制备抗氧化的食品或药品中的应用 | |
Chrzanowska-Lightowlers et al. | 175th ENMC International Workshop: mitochondrial protein synthesis in health and disease, 25–27th June 2010, Naarden, The Netherlands | |
NO20015330L (no) | Ny promoter for genekspresjon | |
Fukuchi et al. | Lysine 271 but not lysine 210 of XRCC4 is required for the nuclear localization of XRCC4 and DNA ligase IV | |
JP2007525203A5 (no) | ||
Bell et al. | Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity | |
Hierck et al. | A chicken model for DGCR6 as a modifier gene in the DiGeorge critical region | |
Nanbu et al. | Enhanced Stability of Urokinase‐Type Plasminogen Activator mRNA in Metastatic Breast Cancer MDA‐MB‐231 Cells and LLC‐PK1 Cells Down‐Regulated for Protein Kinase C—Correlation with Cytoplasmic Heterogeneous Nuclear Ribonucleoprotein C | |
Pedraza et al. | A retinoic acid-responsive element in human midkine gene | |
Adriaansen et al. | Local delivery of beta interferon using an adeno-associated virus type 5 effectively inhibits adjuvant arthritis in rats | |
Caudal et al. | Harnessing human genetics and stem cells for precision cardiovascular medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |